July 2016 – Policy & Medicine

Ubl Gets Personal, Lays Out Vision for Future of PhRMA

The Olympus Settlement – What It Can Tell Us About the Compliance Officer

FDA Guidance Data Integrity and Compliance With CGMP

Give Thanks for Your Compliance Officers – Reviewing Public Citizen’s Study of Pharmaceutical Settlements

Acclarent Executive Convicted of Misdemeanors and Acquitted of Felonies

It’s A Brave New World or Is It? – CIAs and Their Ability to Create Change

FDA: Draft Guidance – Procedures for Evaluating Appearance Issues and Granting Authorizations for Participation in FDA Advisory Committees

CMS Hosting Special Open Door Forum on Open Payments and the 2017 Physician Fee Schedule

CMS Reports $42 Billion Saved in Medicare and Medicaid

Unlikely Bedfellows: SEC Penalties When Industry Fails to Disclose FDA Recommendations for Clinical Trials